Jane Street Group, LLC Neurocrine Biosciences Inc Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

A detailed history of Jane Street Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 199,220 shares of NBIX stock, worth $28.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,220
Previous 7,082 2713.05%
Holding current value
$28.9 Million
Previous $890,000 3042.25%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$123.98 - $146.67 $23.8 Million - $28.2 Million
192,138 Added 2713.05%
199,220 $28 Million
Q2 2025

Aug 14, 2025
SELL
$87.54 - $128.18 $407,936 - $597,318
-4,660 Reduced 39.69%
7,082 $890,000
Q1 2025

May 19, 2025
SELL
$107.22 - $153.29 $2.38 Million - $3.4 Million
-22,200 Reduced 65.41%
11,742 $1.3 Million
Q1 2025

May 14, 2025
SELL
$107.22 - $153.29 $7.06 Million - $10.1 Million
-65,828 Reduced 65.98%
33,942 $3.75 Million
Q4 2024

Feb 14, 2025
BUY
$111.62 - $139.44 $8.4 Million - $10.5 Million
75,254 Added 306.96%
99,770 $13.6 Million
Q3 2024

Nov 14, 2024
SELL
$114.58 - $153.15 $9.86 Million - $13.2 Million
-86,042 Reduced 77.83%
24,516 $2.82 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $18.5 Million - $20.3 Million
-141,446 Reduced 56.13%
110,558 $15.2 Million
Q1 2024

May 15, 2024
BUY
$130.4 - $143.74 $31.1 Million - $34.2 Million
238,124 Added 1715.59%
252,004 $34.8 Million
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $7.84 Million - $9.82 Million
-73,958 Reduced 84.2%
13,880 $1.83 Million
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $2.98 Million - $3.71 Million
31,683 Added 56.42%
87,838 $9.88 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $767,898 - $899,469
-8,577 Reduced 13.25%
56,155 $5.3 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $4.2 Million - $5.49 Million
44,617 Added 221.81%
64,732 $6.55 Million
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $11.8 Million - $14 Million
-110,298 Reduced 84.58%
20,115 $2.4 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $7.6 Million - $8.9 Million
82,597 Added 172.74%
130,413 $13.9 Million
Q2 2022

Aug 16, 2022
SELL
$75.79 - $100.07 $6.36 Million - $8.4 Million
-83,943 Reduced 63.71%
47,816 $4.66 Million
Q1 2022

May 17, 2022
SELL
$72.45 - $94.81 $3.58 Million - $4.68 Million
-49,408 Reduced 27.27%
131,759 $12.4 Million
Q4 2021

Feb 15, 2022
BUY
$79.65 - $106.22 $3.98 Million - $5.31 Million
49,957 Added 38.07%
181,167 $15.4 Million
Q3 2021

Nov 16, 2021
BUY
$86.18 - $99.03 $9 Million - $10.3 Million
104,441 Added 390.16%
131,210 $12.6 Million
Q2 2021

Aug 16, 2021
SELL
$89.43 - $102.27 $2.82 Million - $3.22 Million
-31,478 Reduced 54.04%
26,769 $2.61 Million
Q1 2021

May 18, 2021
SELL
$87.57 - $119.4 $972,552 - $1.33 Million
-11,106 Reduced 16.01%
58,247 $5.67 Million
Q4 2020

Feb 17, 2021
SELL
$86.91 - $108.33 $329,041 - $410,137
-3,786 Reduced 5.18%
69,353 $6.65 Million
Q3 2020

Nov 17, 2020
BUY
$96.16 - $135.15 $2.06 Million - $2.9 Million
21,446 Added 41.49%
73,139 $7.03 Million
Q2 2020

Aug 17, 2020
BUY
$85.09 - $130.36 $3.66 Million - $5.6 Million
42,979 Added 493.22%
51,693 $6.31 Million
Q1 2020

May 15, 2020
BUY
$75.11 - $113.76 $194,009 - $293,842
2,583 Added 42.13%
8,714 $755,000
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $9,634 - $13,161
111 Added 1.84%
6,131 $659,000
Q3 2019

Nov 14, 2019
SELL
$83.82 - $101.5 $4,693 - $5,684
-56 Reduced 0.92%
6,020 $542,000
Q2 2019

Aug 15, 2019
BUY
$72.24 - $91.27 $168,969 - $213,480
2,339 Added 62.59%
6,076 $513,000
Q1 2019

May 16, 2019
SELL
$69.31 - $91.53 $155,531 - $205,393
-2,244 Reduced 37.52%
3,737 $329,000
Q4 2018

Feb 15, 2019
SELL
$68.32 - $124.36 $1.2 Million - $2.18 Million
-17,552 Reduced 74.58%
5,981 $427,000
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $2.05 Million - $2.61 Million
20,763 Added 749.57%
23,533 $2.89 Million
Q2 2018

Aug 15, 2018
SELL
$75.3 - $105.99 $1.28 Million - $1.8 Million
-16,963 Reduced 85.96%
2,770 $272,000
Q1 2018

May 15, 2018
BUY
$75.88 - $92.43 $1.02 Million - $1.24 Million
13,462 Added 214.67%
19,733 $1.64 Million
Q4 2017

Feb 15, 2018
SELL
$58.53 - $77.59 $598,644 - $793,590
-10,228 Reduced 61.99%
6,271 $487,000
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $791,457 - $1.01 Million
16,499
16,499 $1.01 Million

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email